Target intelligence / Profile preview

Viral RNA sequence (null)

Target
null
Molecular classification
Nucleic acid, Genome, Other
01

Overview

A **viral RNA sequence** is a strand or molecule of ribonucleic acid that constitutes the genetic material of RNA viruses. Depending on the virus classification, it can be single-stranded (positive- or negative-sense), double-stranded, or part of a segmented genome. Viral RNA sequences encode the genes necessary for the synthesis of viral proteins, genome replication, and packaging. These sequences are central to the biology of RNA viruses, mediate host-pathogen interactions, and serve as direct targets for antiviral drugs, molecular diagnostics (such as RT-PCR), and RNA-targeting therapies. Due to their diversity and central role in viral biology, viral RNA sequences are critical therapeutic and diagnostic targets but are not a specific molecular entity like a protein or receptor. **Note:** - The entry "Viral RNA sequence" is *not the name of a specific target molecule*, receptor, or protein but a general descriptor for the genome or genetic material of any RNA virus. For structured databases or target mappings, more precise identifiers (e.g., "SARS-CoV-2 genomic RNA", "HCV RNA genome") should be used for target-specific annotations.

Other names
Viral RNARNA genome of virusViral genomic RNAViral transcript (context-dependent)Positive-sense viral RNA (for +ssRNA viruses)Negative-sense viral RNA (for -ssRNA viruses)
02

Mechanism of action

Inhibition of RNA-dependent RNA polymerase (RdRp) to prevent viral RNA synthesis Direct RNA targeting via antisense oligonucleotides or small interfering RNAs (siRNA) Induction of lethal mutagenesis (as some nucleoside analogues cause error catastrophe in RNA replication)

03

Biological functions

Genetic information storageTemplate for replication and transcriptionTemplate for translation (in +ssRNA viruses)Regulation of viral gene expressionInitiation of viral life cycle
04

Disease associations

Infection (central in all RNA virus-related infection)Cancer (for oncogenic RNA viruses, e.g., HCV, HTLV)Other
05

Safety considerations

Risk of off-target effects with nucleic acid-based therapiesViral mutational escape may reduce detection or drug efficacyToxicity of nucleoside analogues in host cellsDiagnostic false-negatives due to low RNA abundance or viral sequence variation
06

Interacting drugs

Remdesivir (broad-spectrum RdRp inhibitor; targets RNA synthesis of several viruses)

4 more in the full profile.

07

Biomarkers

Viral RNA levels in patient samples (plasma, swab, etc.) used for diagnosis, prognosis, and monitoring of infection (e.g., RT-PCR for SARS-CoV-2, HCV RNA quantification)

Beyond the preview

Go deeper on Viral RNA sequence (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Viral RNA sequence (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call